The Globe and Mail

Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business

Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value ...

Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

Marks Aclarion’s first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and ...
Investing

Johnson & Johnson to separate orthopaedics business into standalone entity

NEW BRUNSWICK, N.J. - Johnson & Johnson (NYSE:JNJ) announced Tuesday its plan to separate its orthopaedics business, which will operate as a standalone company under the DePuy Synthes name. The ...

Advita Ortho Launches to Advance Patient Lives through Orthopedic Innovation

Advita Ortho, LLC, today announces its official launch as a global medical device company dedicated to advancing patients' ...
PharmiWeb

Orthopedic Implants Market Subjected to Grow at a CAGR of ~4% BY 2030 Due to Increasing Geriatric Population, Rising Incidence of Chronic Conditions : Medi-Tech Insights

The global orthopedic implants market is expected to grow at a CAGR of ~4% during the forecast period. Increasing geriatric population, rising incidence of chronic conditions such as osteoarthritis ...
Managing Intellectual Property

Tariff strategy to IP vulnerability: how corporate restructuring can damage patent enforcement and remedies

Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering ...
akm

American Johnson&Johnson intends to separate orthopedic business in DePuy Synthes

The American pharmaceutical company Johnson & Johnson plans to separate the orthopedic business into a separate company under the brand name DePuy Synthes within 18-24 months. This is reported in a ...
Pharm Exec

Johnson and Johnson Reveals Plan to Separate Orthopaedics Business

Johnson & Johnson will separate its orthopaedics business to create DePuy Synthes, enhancing strategic focus and stakeholder value. The separation aims to strengthen Johnson & Johnson's focus on ...
NDTV

Alarming Rise Of Spinal Problems: 5 Most Common Spine Issues Affecting Indians, Prevention Tips

Spinal health issues are becoming a silent epidemic in India. According to the World Health Organization (WHO), low back pain is now the leading cause of disability worldwide, and India is no ...
Indiatimes

Get rid of hunchback: Try these 5 simple exercises to straighten the spine

Spending long hours hunched over desks and phones can lead to postural hyperkyphosis, causing pain and affecting mobility. Fortunately, targeted exercises like chin retractions, foam rolling, and wall ...
PharmiWeb

Revolutionizing Orthopedic Recovery: Global Insights into the Calcium Phosphate Bone Cement Market Growth Through 2032

The global Calcium Phosphate Bone Cement Market is on a steady path of expansion, reflecting the increasing intersection of ...
Wall Street Journal

Johnson & Johnson to Split Off Orthopedics Business

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.